Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Feb. 03, 2011	Jul. 03, 2006
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Acquired share capital of Bio-Maxtrix Scientific Gruop, Inc.				100.00%
Consideration of shares of common stock of the Company				10,000,000
Cancelation of shares of the Company owned and held by John Lauring				10,000,000
Percent of voting capital stock of the Company held by former stockholder of BMSG				80.00%
Owned subsidiary, Regen BioPharma, Inc.			96.00%
Shares of Entest BioMedical, Inc. for Securities Available for Sale	10,000,000
Note receivable from Entest BioMedical	$ 12,051
Advertising expenses	$ 0	$ 0